Skip to main navigation
Skip to search
Skip to main content
Columbia University Home
Help & FAQ
English
Français
Español
Home
Profiles
Research units
Research output
Equipment
Datasets
Projects & Clinical Trials
Activities
Prizes
Courses
Student theses
Search by expertise, name or affiliation
View Scopus Profile
Gen Li
Mailman School of Public Health
h-index
h10-index
h5-index
13281
Citations
31
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
13281
Citations
31
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
3616
Citations
17
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2018
2022
Research activity per year
Overview
Fingerprint
Network
Projects & Clinical Trials
(3)
Research output
(4)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Gen Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
Enhancer Region
75%
Genetic Divergence
69%
Expression Quantitative Trait Loci
66%
Genotyping
58%
Transcriptome
48%
BRD4
46%
Genetic Variation
45%
Transcription Factors
43%
RNA Sequence
41%
Transcriptomics
37%
Programmed Cell Death
36%
Genetics
34%
Long Non-Coding RNA
34%
Myeloid
34%
Anticancer
34%
Genomics
33%
RNA Sequencing
30%
Ubiquitination
26%
Genetic Determinism
25%
Rare Variant
24%
P53
22%
Immunity
22%
Microbiome
22%
Binding Protein
22%
RNA
22%
Allele
22%
Cell Proliferation
21%
Genetic Regulation
21%
Overall Survival
21%
Cell Cycle
20%
down Regulation
20%
Deubiquitinating Enzyme
19%
Cell Growth
19%
Carcinogenesis
17%
Transcription
17%
Myc
17%
Bioinformatics
17%
Ubiquitin
16%
Western Blot
15%
Protease
15%
Oncogene
14%
Cancer Cell
14%
Lipid Metabolism
14%
Small Hairpin RNA
14%
Taxon
14%
Genome Wide Association Study
14%
Demethylase
14%
Gene Signature
14%
Gene Control
13%
Medicine and Dentistry
Breast Cancer
45%
Neoplasm
41%
Transcription Factors
36%
Enhancer Region
35%
Systematic Review
34%
Muscle Invasive Bladder Cancer
34%
Meta-Analysis
34%
Biological Marker
31%
Logistic Regression Analysis
25%
Urologist
25%
Bladder Tumor
25%
Transurethral Resection
25%
Cystectomy
24%
Urethroplasty
22%
Non Muscle Invasive Bladder Cancer
22%
Ureter Injury
22%
Urinary Tract Infection
22%
Cohort Analysis
22%
Gut Microbiome
22%
Microbiome
22%
Acute Kidney Injury
22%
Acute Myeloid Leukemia
22%
Immunity
22%
Melanoma
22%
Diseases
22%
Primary Health Care
21%
Malignant Neoplasm
21%
Recurrent Disease
19%
Transitional Cell Carcinoma
19%
Leukemia Cell
18%
Bladder Cancer
17%
Proportional Hazards Model
16%
Nerve Cell Differentiation
14%
Cell Growth
14%
Macrophage
13%
COVID-19
13%
Injury
13%
Urologic Surgery
13%
Minimally Invasive Procedure
13%
Cell Survival
13%
Cell Line
12%
Cystoscopy
12%
Neonates
12%
Bladder
12%
Squamous Cell Carcinoma
11%
Prostate Cancer
11%
Bladder Injury
11%
Neoadjuvant Chemotherapy
11%
Health Service
11%
Glucose Intolerance
11%
Immunology and Microbiology
Enhancer Region
49%
Transcription Factors
37%
Neuroblastoma Cell
35%
Xenograft
35%
Microbiome
34%
RNA Sequencing
34%
Ubiquitination
32%
Programmed Cell Death
29%
Macrophage
25%
Cell Proliferation
24%
Oncogene
23%
Immunity
22%
Cell Growth
22%
Cell Cycle
17%
Gene Expression
17%
Ubiquitins
17%
Gut Microbiome
15%
Taxon
14%
Inflammation Response
13%
Western Blot
13%
Transcriptome
13%
Muscle
13%
Fibrinogen
12%
Leukemia Cell
12%
Mouse Model
12%
Viral Disease
11%
Endoplasmic reticulum
11%
Cadherin
11%
Microflora
11%
Glucose Blood Level
11%
P53
11%
Growth Regulation
11%
Secretome
11%
Cytotoxic Lymphocyte
11%
MAPK Signaling
11%
Hairless
11%
Skin Cell
11%
Antibacterial Activity
11%
Mycoplasma pneumoniae
11%
Normal Human
11%
RNA Polymerase
11%
Cell Cycle Arrest
11%
Protein Family
11%
Initiation Factor 4E Binding Protein 1
11%
Initiation Factor 4E
11%
Prostate
11%
Human Tissue
11%
Protein Degradation
11%
Multi-Omics
11%
Cycline
11%
